Abstract:BACKGROUND: Delayed fracture healing causes substantial disability and usually requires additional surgical treatments. Pharmacologic management to improve fracture repair would substantially improve patient outcome. The signaling pathways regulating bone healing are beginning to be unraveled, and they provide clues into pharmacologic management. The beta-catenin signaling pathway, which activates T cell factor (TCF)-dependent transcription, has emerged as a key regulator in embryonic skeletogenesis, positively regulating osteoblasts. However, its role in bone repair is unknown. The goal of this study was to explore the role of beta-catenin signaling in bone repair.METHODS AND FINDINGS: Western blot analysis showed significant up-regulation of beta-catenin during the bone healing process. Using a beta-Gal activity assay to observe activation during healing of tibia fractures in a transgenic mouse model expressing a TCF reporter, we found that beta-catenin-mediated, TCF-dependent transcription was activated in both bone and cartilage formation during fracture repair. Using reverse transcription-PCR, we observed that several WNT ligands were expressed during fracture repair. Treatment with DKK1 (an antagonist of WNT/beta-catenin pathway) inhibited beta-catenin signaling and the healing process, suggesting that WNT ligands regulate beta-catenin. Healing was significantly repressed in mice conditionally expressing either null or stabilized beta-catenin alleles induced by an adenovirus expressing Cre recombinase. Fracture repair was also inhibited in mice expressing osteoblast-specific beta-catenin null alleles. In stark contrast, there was dramatically enhanced bone healing in mice expressing an activated form of beta-catenin, whose expression was restricted to osteoblasts. Treating mice with lithium activated beta-catenin in the healing fracture, but healing was enhanced only when treatment was started subsequent to the fracture.CONCLUSIONS: These results demonstrate that beta-catenin functions differently at different stages of fracture repair. In early stages, precise regulation of beta-catenin is required for pluripotent mesenchymal cells to differentiate to either osteoblasts or chondrocytes. Once these undifferentiated cells have become committed to the osteoblast lineage, beta-catenin positively regulates osteoblasts. This is a different function for beta-catenin than has previously been reported during development. Activation of beta-catenin by lithium treatment has potential to improve fracture healing, but only when utilized in later phases of repair, after mesenchymal cells have become committed to the osteoblast lineage.

β-Catenin in the race to fracture repair: in it to Wnt

Wnt Signaling:Essential Roles in Osteoblast Differentiation,bone Metabolism and Therapeutic Implications for Bone and Skeletal Disorders

[Crosstalk Between Canonical TGF-β/Smad and Wnt/β-catenin Signaling Pathway].

Beta-Catenin Signaling Plays a Disparate Role in Different Phases of Fracture Repair: Implications for Therapy to Improve Bone Healing

Wnt pathway, an essential role in bone regeneration

Wnt/β-catenin signaling components and mechanisms in bone formation, homeostasis, and disease

The Wnt Signaling Pathway as a Potential Target for Therapies to Enhance Bone Repair

Role of Wnt signaling in fracture healing

An appropriate Wnt/β-catenin expression level during the remodeling phase is required for improved bone fracture healing in mice

Wnt/β-Catenin Signaling and Disease

Advances in Research on the Mechanism of Canonical Wnt Signaling in Bone Remodeling

Role of Wnt Signaling in Bone Remodeling and Repair

Molecular regulation and pharmacological targeting of the β-catenin destruction complex

Wnt Pathway in Bone Repair and Regeneration – What Do We Know So Far

Wnt and the Wnt signaling pathway in bone development and disease

Wnt/β-catenin Singal Transduction Pathway and Colorectal Cancer

The PI3K/AKT pathway promotes fracture healing through its crosstalk with Wnt/β-catenin

Wnt signaling: A win for bone

Inhibition of Ss-Catenin Signaling in Chondrocytes Induces Delayed Fracture Healing in Mice

Targeting Wnt/β-Catenin Pathway for Drug Therapy